The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma
Open accessAbstract
Summary: Euglycemic diabetic ketoacidosis (EDKA) is a clinical triad comprising increased anion gap metabolic acidosis, ketonemia or ketonuria and normal blood glucose levels <200 mg/dL. This condition is a diagnostic challenge as euglycemia masquerades the underlying diabetic ketoacidosis. Thus, a high clinical suspicion is warranted, and other diagnosis ruled out. Here, we present two patients on regular insulin treatment who were admitted with a diagnosis of EDKA. The first patient had insulin pump failure and the second patient had urinary tract infection and nausea, thereby resulting in starvation. Both of them were aggressively treated with intravenous fluids and insulin drip as per the protocol for the blood glucose levels till the anion gap normalized, and the metabolic acidosis reversed. This case series summarizes, in brief, the etiology, pathophysiology and treatment of EDKA. Learning points: Euglycemic diabetic ketoacidosis is rare. Consider ketosis in patients with DKA even if their serum glucose levels are normal. High clinical suspicion is required to diagnose EDKA as normal blood sugar levels masquerade the underlying DKA and cause a diagnostic and therapeutic dilemma. Blood pH and blood or urine ketones should be checked in ill patients with diabetes regardless of blood glucose levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There is a potential risk of severe hypoglycemia if persons with DM do not appropriately reduce the prandial insulin dosage.1171–1174”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1173]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tachyphylaxis is often seen after several years of therapy.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1173]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Nausea is a common adverse effect.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1173]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Rosenstock, J., & Ferrannini, E. (2015) · Diabetes Care · doi:10.2337/dc15-1380 · Cited by 664
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2015) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 336
Euglycaemic Diabetic Ketoacidosis
Munro, J., Campbell, I. W., McCuish, A. C., & Duncan, L. J. P. (1973) · BMJ · doi:10.1136/bmj.2.5866.578 · Cited by 322
Qiu, H., Novikov, A., & Vallon, V. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2886 · Cited by 227
Euglycemic Diabetic Ketoacidosis: A Review.
Modi, A. D., Agrawal, A., & Morgan, F. (2017) · PubMed · doi:10.2174/1573399812666160421121307 · Cited by 115
Burge, M. R., Hardy, K. J., & Schade, D. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8496310 · Cited by 98
Starvation-induced True Diabetic Euglycemic Ketoacidosis in Severe Depression
Joseph, F., Anderson, L., Goenka, N., & Vora, J. P. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0829-0 · Cited by 83
Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.
Burge, M., García, N., Qualls, C., & Schade, D. (2001) · Metabolism: Clinical and Experimental · doi:10.1053/meta.2001.20194 · Cited by 72
Normoglycemic diabetic ketoacidosis in pregnancy
Chico, M. S., Levine, S. N., & Lewis, D. F. (2008) · Journal of Perinatology · doi:10.1038/sj.jp.7211921 · Cited by 63
Cited by
Sorted by citations
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Euglycemic diabetic ketoacidosis: A missed diagnosis
Nasa, P., CHAUDHARY, S. K., Shrivastava, P. K., & Singh, A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i5.514 · Cited by 180
Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors
Chow, E., Clement, S. C., & Garg, R. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003666 · Cited by 183
Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management
Long, B., Lentz, S., Koyfman, A., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.02.015 · Cited by 150
Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
Yu, X., Zhang, S., & Zhang, L. (2018) · International Journal of Endocrinology · doi:10.1155/2018/7074868 · Cited by 102
Diaz-Ramos, A., Eilbert, W. P., & Marquez, D. (2019) · International Journal of Emergency Medicine · doi:10.1186/s12245-019-0240-0 · Cited by 98
Dutta, S., Kumar, T., Singh, S., Ambwani, S. R., Charan, J., & Varthya, S. B. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_644_21 · Cited by 71
Ketoacidosis and SGLT2 Inhibitors: A Narrative Review
Morace, C., Lorello, G., Bellone, F., Quartarone, C., Ruggeri, D., Giandalia, A., Mandraffino, G., Minutoli, L., Squadrito, G., Russo, G. T., et al. (2024) · Metabolites · doi:10.3390/metabo14050264 · Cited by 67
Somagutta, M. K. R., Agadi, K., Hange, N., Jain, M. S., Batti, E., Emuze, B. O., Amos-Arowoshegbe, E. O., Popescu, S., Hanan, S., Kumar, V. R., et al. (2021) · Cureus · doi:10.7759/cureus.13665 · Cited by 63
Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA
Muneer, M. A., & Akbar, I. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_545 · Cited by 66
Lizzo, J. M., Goyal, A., & Gupta, V. (2021) · StatPearls · Cited by 49
Bamgboye, A. O., Oni, I. O., & Collier, A. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03051-3 · Cited by 48
Euglycemic Diabetic Ketoacidosis
Plewa, M. C., Bryant, M. G., & King-Thiele, R. (2021) · StatPearls · Cited by 47
Comorbidities of COVID-19 Patients
Silaghi-Dumitrescu, R. L., Patrascu, I., Lehene, M., & Bercea, I. (2023) · Medicina · doi:10.3390/medicina59081393 · Cited by 61
DIABETIC KETOACIDOSIS ASSOCIATED WITH ANTIPSYCHOTIC DRUGS: CASE REPORTS AND A REVIEW OF LITERATURE
Vuk, A., Kuzman, M. R., Baretić, M., & Osvatić, M. M. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.121 · Cited by 46
Alamoudi, R. M., AlSubaiee, M., Alqarni, A., Al‐Saleh, Y., Aljaser, S., Salam, A., & Eledrisi, M. S. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0418 · Cited by 45
Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state
Hassan, E. M., Mushtaq, H. A., Mahmoud, E. E., Chhibber, S., Saleem, S., Issa, A., Jain, N., Jama, A. B., Khedr, A., Boike, S., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i32.11702 · Cited by 43
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
Koutentakis, M., Kuciński, J., Świeczkowski, D., Surma, S., Filipiak, K. J., & Gąsecka, A. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10110465 · Cited by 30
From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
Koceva, A., & Tramšek, N. A. K. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070665 · Cited by 20
Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes
Alduraibi, R. K., Alrebdi, Y. M., & Altowayan, Y. F. (2023) · Medicine · doi:10.1097/md.0000000000034027 · Cited by 20
Berger, B., Jenetzky, E., Köblös, D., Stange, R., Baumann, A., Simstich, J., Michalsen, A., Schmelzer, K., & Martin, D. D. (2021) · Nutrition · doi:10.1016/j.nut.2021.111169 · Cited by 19
Euglycemic DKA (euDKA) as a presentation of COVID‐19
Dass, B., Beck, A., Holmes, C., & Morton, G. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3540 · Cited by 18
Influence of Hyperglycemia Associated with Enteral Nutrition on Mortality in Patients with Stroke
Gómez, J. J. L., Delgado-García, E., Coto-García, C., Torres-Torres, B., Hoyos, E. G., Valles, C. S., Castro-Lozano, Á., Arenillas, J. F., & de Luis, D. A. (2019) · Nutrients · doi:10.3390/nu11050996 · Cited by 18
Giaccari, A., Pontremoli, R., & Filardi, P. P. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.12.050 · Cited by 18
Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication
Abdin, A. A.-A., Hamza, M., Khan, M., & Ahmed, A. (2016) · Case Reports in Critical Care · doi:10.1155/2016/4275651 · Cited by 17
Pancreatic cancer trends in Europe: epidemiology and risk factors
Hawksworth, G., Hales, J., Martinez, F., Hynes, A., Hamilton, A., & Fernández, V. (2019) · Medical Studies · doi:10.5114/ms.2019.86336 · Cited by 16
Garay, P. A. S., Zúñiga, G., & Lichtenberg, R. (2020) · Clinical Diabetes · doi:10.2337/cd19-0055 · Cited by 15
Singh, S., Rushakoff, R. J., & Neinstein, A. B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819838875 · Cited by 14
Re-emergence of a forgotten diabetes complication
Dağdeviren, M., Akkan, T., & Ertuğrul, D. T. (2024) · Turkish Journal of Emergency Medicine · doi:10.4103/tjem.tjem_110_23 · Cited by 12
Inpatient Glycemic Management of the Pregnant Patient
Yeh, T., Yeung, M., & Curanaj, F. A. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1045-x · Cited by 13
Aggarwal, A., Jain, A., Sachdeva, S., & Kulairi, Z. I. (2020) · Cureus · doi:10.7759/cureus.11554 · Cited by 11
Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide
Louwagie, E. J., Diego, J. N., Farooqi, C. S., & Kamal, M. M. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf028 · Cited by 10
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
Mederle, A. L., Dumitrescu, P., Borza, C., & Kundnani, N. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010188 · Cited by 9
PROFILE OF DIABETIC KETOACIDOSIS PATIENTS AT REGIONAL PUBLIC HOSPITAL DR. SOETOMO IN 2017
Dewata, D. G. U. B., Novida, H., & Aryati, A. (2020) · Jurnal Berkala Epidemiologi · doi:10.20473/jbe.v8i32020.301-309 · Cited by 9
Postoperative extremity gangrene in a patient with type 2 diabetes taking SGLT2 inhibitors
Wong, Y. C., Liu, K., & Lee, C.-L. (2021) · Medicine · doi:10.1097/md.0000000000025590 · Cited by 9
Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
Alhemeiri, M., & Alseddeeqi, E. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/4101975 · Cited by 9
Euglycemic diabetic ketoacidosis in pregnancy with COVID‐19: A case report and literature review
Wazir, S., Shittu, S. A., Dukhan, K., Sharief, M., Beer, S. F., Malik, W. A., & Alansari, L. M. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5680 · Cited by 9
Mahikul, W., White, L. J., Poovorawan, K., Soonthornworasiri, N., Sukontamarn, P., Chanthavilay, P., Ngum, W. P., & Medley, G. F. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16122207 · Cited by 12
Euglycemic diabetic ketoacidosis in a pregnant woman
Algaly, G., Abdelrahman, A., & Ahmed, S. M. I. (2023) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13089 · Cited by 8
Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
Chauhan, S., Manov, A. E., Dhillon, G. S., & Shah, P. (2023) · Cureus · doi:10.7759/cureus.33892 · Cited by 7
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
Sexe, J., Mayes, C., & Tofts, P. (2020) · Case Reports in Critical Care · doi:10.1155/2020/7437892 · Cited by 7
Gandecka, A., Naskręt, D., Adamska, A., & Zozulińska‐Ziółkiewicz, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1649270 · Cited by 6
Health Literacy of Migrant Workers in Saudi Arabia: A Cross-sectional Survey
Alhamidi, S. A., & Alyousef, S. M. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525099 · Cited by 6
Lateef, S., Komal, N., Ghaffar, M., Zulfiqar, K., Minhas, S., Mumtaz, H., Zakria, M., Salman, M., Sulaimani, S. Y., & Khan, S. E. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525098 · Cited by 6
Bardhi, O., Bloom, M. D., & Sattari, M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-247921 · Cited by 6
A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide
Huang, M., Liu, G., Zhang, C., Wang, Y., Liu, S., & Zhao, J. L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1608657 · Cited by 8
Tauseef, A., Asghar, M. S., Zafar, M., Lateef, N., & Thirumalareddy, J. (2020) · Cureus · doi:10.7759/cureus.10078 · Cited by 5
Sholevar, C. J., Torjani, A., Kavanagh, T. R., Yudkoff, C., Xiao, K. B., Swaminathan, V., Rshaidat, H., Bowne, W. B., Krampitz, G. W., Nevler, A., et al. (2022) · Surgery · doi:10.1016/j.surg.2022.07.009 · Cited by 5
Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis
Han, H. J., Cole, A. E., & Verma, A. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07993-5 · Cited by 5
Euglycemic Diabetic Ketoacidosis in a Young Pregnant Woman Precipitated by Urinary Tract Infection
Muppidi, V., Meegada, S., Challa, T. R., Siddamreddy, S., & Samal, S. (2020) · Cureus · doi:10.7759/cureus.7331 · Cited by 5
Diabetic Ketoacidosis in an Euglycemic Patient
Mumtaz, H., Shafiq, M. A., Batool, H., Naz, T., & Ambreen, S. (2020) · Cureus · doi:10.7759/cureus.10065 · Cited by 5
Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature
Hernández-Quiles, C., Ramírez‐Duque, N., & Acosta-Delgado, D. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180726114044 · Cited by 5
The Future of Dual Glucose–Ketone Monitoring in Youth with Diabetes
Sherr, J. L., & Cobry, E. C. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251370944 · Cited by 4
Helvacı, B. C., Erdoğan, B. T., Özdemir, D., Topaloğlu, O., & Çakır, B. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0229 · Cited by 4
Hedary, A. S., Melder, L., & Pippin, M. (2024) · Cureus · doi:10.7759/cureus.75399 · Cited by 4
Acosta, A., Fanco, A., Rohan, H. P., & Elfessi, Z. Z. (2025) · JEM Reports · doi:10.1016/j.jemrpt.2025.100139 · Cited by 4
Burgio, A., Alletto, M., Amico, S., Castiglione, U., Fulco, G., Groppuso, C., Gruttadauria, G., Salvaggio, S., Grande, A., & Vancheri, F. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.2018.1061 · Cited by 4
Metformin Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis: A Case Report
Hasnie, U. A., Shen, J. Z., Hasnie, A. A., & Tolwani, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00761-2 · Cited by 4
A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis
Dyatlova, N., Omotosho, Y. B., Sherchan, R., Shrestha, J., & Buddharaju, V. L. (2021) · Cureus · doi:10.7759/cureus.14580 · Cited by 4
Selbie, J. H. J., Hiyama, S., & Pandit, H. G. (2025) · Arthroplasty Today · doi:10.1016/j.artd.2025.101840 · Cited by 3
Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection
Chauhan, S., Díaz, V., Ogbu, I. R., Sanchez, J. R. P., Manov, A. E., & Shah, P. (2024) · Cureus · doi:10.7759/cureus.66408 · Cited by 3
Empagliflozin-Associated Euglycemic Diabtetic Ketoacidosis
Soni, P., Kumar, V., Saradna, A., & Kupfer, Y. Y. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000752 · Cited by 3
Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i.
de Cos, G. V., Acosta, M. I. S.-M., & Fernández, M. M. T. (2021) · PubMed Central · Cited by 3
Alhaj, O., & Afandi, B. O. (2022) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0042-1755440 · Cited by 3
Diabetic Emergencies: Ketoacidosis, Hyperglycemic Hyperosmolar State, and Hypoglycemia
Guzman, H., & Lam, D. W.-H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00015-6 · Cited by 3
Zaher, E. A., Alromaih, W. R., Alotaibi, A. S., Almughairy, A. A., Alqarfan, A. A., & Alheji, Z. A. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525095 · Cited by 3
SGLT inhibitors and euglycaemic diabetic ketoacidosis: earlier observations rediscovered
Beshyah, S., & Frier, B. M. (2019) · British Journal of Diabetes · doi:10.15277/bjd.2019.214 · Cited by 3
Association between SGLT2 inhibitors and diabetic ketoacidosis among patients fasting in RamadanPreprint
Ruqaib, A. M. A., Alghamdi, A. A., Jamaan, A. A., Abdulmowla, M. M., Deaji, F. F. A., & Alsuwaidan, S. D. (2023) · Research Square · doi:10.21203/rs.3.rs-2466697/v1 · Cited by 3
Severe Euglycemic Ketoacidosis Secondary to Tirzepatide Use for Weight Loss
Hassan, A. (2026) · Cureus · doi:10.7759/cureus.107028 · Cited by 2
Acute hyperglycemic emergencies
Kubacka, B. (2019) · Nursing Critical Care · doi:10.1097/01.ccn.0000553076.18411.12 · Cited by 3
Manejo de la cetoacidosis diabética
Elizondo, D. S. P., Morales, K. P. C., & Fernández, R. V. (2022) · Revista Medica Sinergia · doi:10.31434/rms.v7i7.864 · Cited by 2
Ghamri, R. A., & Faidah, S. O. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525104 · Cited by 2
Euglycemic Diabetic Ketoacidosis in the Setting of Dulaglutide Use
Patel, N., Reddy, A. D., Romero, K. N., & Reddy, P. (2025) · Cureus · doi:10.7759/cureus.82143 · Cited by 2
Almascati, Y., & Alhumaiqani, A. (2025) · Cureus · doi:10.7759/cureus.84170 · Cited by 2
Pancreatic ketoacidosis-a rare case report
Dhivahar, G., Rajan, P., Raghunath, D., & Misra, S. (2020) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2020.i01.21 · Cited by 2
Diabetic emergencies presenting during the COVID‐19 pandemic: A retrospective case analysis
Joseph, T., Crawley, E., Qamar, S., Zosmer, M., Rayanagoudar, G., Nethaji, C., & Menon, R. K. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.313 · Cited by 2
Thompson, B., & Kitchen, A. (2021) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2021.1.48905 · Cited by 2
Kinoshita, M., Azuma, K., & Yanagawa, T. (2022) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2022.100124 · Cited by 2
Instituto de Salud del Estado de México. Calixtlahuaca, T., Sanchez, D. S. M., Larios, J. F. D. P., Instituto de Salud del Estado de México. Calixtlahuaca, T., Salas, J. M. G., Instituto de salud del Estado de México, C. E. D. A. P. A. L. S. S. J. D. L. H., Salazar, J. A. D., Jurisdicción IX Ameca; Centro de Salud. San Marcos, J., García, G. L., & Instituto de salud del Estado de México, C. E. D. A. P. A. L. S. S. J. D. L. H. (2023) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v3-i4-22 · Cited by 2
Newer Outpatient Diabetes Therapies and Technologies
Kamal, N., Lee, K., & Aleppo, G. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.002 · Cited by 2
Euglycemic DKA (euDKA) as a presentation of COVID19Preprint
Dass, B., Beck, A., Holmes, C., & Morton, G. (2020) · doi:10.22541/au.160029802.20911437 · Cited by 2
A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
Rao, S. J., Kumar, K., & Saleh, N. (2022) · Cureus · doi:10.7759/cureus.30106 · Cited by 1
Pai, M.-A. T., Wu, T.-K., Chien, S.-W., Chen, C., Kuo, Y.-C., Chen, H.-P., Tseng, T.-Y., & Lim, P. (2023) · 童綜合醫學雜誌 · doi:10.4103/etmj.etmj-d-23-00018 · Cited by 1
Unmasking the risk: euglycemic diabetic ketoacidosis induced by GLP-1 agonist in type 2 diabetes
Adrejiya, P., Alhujaily, E., Abubaker, M., Dorenbush, C., & Khouzam, R. N. (2025) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2025.2555778 · Cited by 1
大史, 福., 健, 蛯., 昭久, 小., 丈太郎, 舘., 裕司, 小., & 順, 織. (2023) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12805 · Cited by 1
SGLT-2i associated diabetic ketoacidosis in the setting of cardiogenic shock
Guzner, A., Downs, I. A., Cruz, D., Kaneshiro, C., & Donangelo, I. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-258017 · Cited by 1
Mottling as an early sign of euglycemic ketoacidosis induced by SGLT-2 inhibitors
Memeti, B., Brombacher, F., Perger, L., & Russmann, S. (2025) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2025_005210 · Cited by 1
Magbri, A. (2017) · Journal of Cardiology and Cardiovascular Sciences · doi:10.29245/2578-3025/2018/1.1108 · Cited by 1
Atypical Euglycemic Ketoacidosis in a non-diabetic Patient due to acute pancreatitis
Manov, A. E., & Ogbu, I. R. (2021) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2021.11.3.0461 · Cited by 1
A review of the uses of the ketogenic diet
Ahmed, Q. A., Abdullah, K., & Mutar, W. M. (2022) · Kirkuk University Journal-Scientific Studies · doi:10.32894/kujss.2022.132824.1058 · Cited by 1
Management of Diabetic Ketoacidosis in Patients with Diabetes Type I
Sindi, B. Z., Alazwari, N. M., & Khateeb, A. M. (2017) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0041530
PREVALENCE OF DIABETIC KETOACIDOSIS AND ITS ETIOLOGICAL FACTORS IN THE PODILLYA REGION OF UKRAINE
Nezhinskaya-Astapenko, Z. P., Sekret, T. V., & Vlasenkо, М. V. (2018) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.18.4.33
Comprehensive review of oncological emergencies seen in clinical practice
Oben, P., & Fein, V. (2019) · Medical Studies · doi:10.5114/ms.2019.84054
Ross, G. P., McGill, M. J., Stewart, M., White, B. J., Zerk, K., Armstrong, S., Deed, G., Rasalam, R. R., Saleh, A., Lam, E., et al. (2020) · ResearchOnline - JCU (James Cook University)
Pinedo-Lechuga, M., Ramírez, R. V., & Corona, P. M. (2020) · Medicina Crítica · doi:10.35366/95880
Clinical Practice and Cases in Emergency Medicine
Saucedo, C., & Nguyen, T. (2021) · Clinical Practice and Cases in Emergency Medicine · doi:10.5811/cpcem.2021.4.54351
Magbri, A., El-Magbri, E., El-Magbri, M., Brar, B., & Rashid, S. (2019) · doi:10.31221/osf.io/f4xub
Magbri, A., El-Magbri, E., El-Magbri, M., Brar, B., & Rashid, S. (2019) · doi:10.31227/osf.io/zbw26
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors use
Correa, C., Franco, V. V., Cáceres, L., Reyes, M., & Loor, Y. (2020) · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · doi:10.18004/rvspmi/2312-3893/2020.07.02.124
Management of Diabetic Ketoacidosis in Patients with Diabetes Type IPreprint
Sindi, B. Z., Alazwari, N. M., Khateeb, A. M., Alzaher, A. A., Alkhawajah, M. A. M., Almutairi, A. K., Al-Mutairi, N. A., & Alghanim, Z. R. (2019) · doi:10.31221/osf.io/tyzdu
Metadata
- Authors
- Rawla, P., Vellipuram, A. R., Bandaru, S. S., & Pradeep Raj, J.
- Affiliations
- Sovah Health Martinsville (US)
- Texas Tech University (US)
- Beth Israel Deaconess Medical Center (US)
- 4Department of Pharmacology, St John’s Medical College, Bangalore, India
- Corresponding author
- Rawla, Prashanth
- Venue
- Endocrinology, Diabetes & Metabolism Case Reports
- Publisher
- Bioscientifica
- Published
- 2017-09-04
- Volume
- 2017
- ISSN
- 2052-0573 (ISSN-L)
- PMC
- PMC5592704
- OpenAlex
- W2752336798
- Cited by
- 139
- References
- 14
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 27 · 2023: 14 · 2022: 29 · 2021: 17 · 2020: 15 · 2019: 11 · 2018: 6 · 2017: 4
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Endocrinology Diabetes and Metabolism Case Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- euglycemic diabetic ketoacidosis, diabetic ketoacidosis, anion gap metabolic acidosis, ketonuria, ketonemia, normoglycemia, starvation, urinary tract infection, intravenous insulin therapy, fluid resuscitation, diabetes mellitus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review